International Patent: NLRP3 INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

GENEVA, Oct. 30 -- HANGZHOU BAICREAT PHARMA-TECH CO., LTD. filed a patent application (CN2026/091949) for “NLRP3 INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF”. With publication no. WO/2026/223618, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/12

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....